Fidia Farmaceutici S.p.a.

This phase 3 trial is testing a drug called ONCOFID-P-B for people with a type of bladder cancer that hasn't responded to standard BCG therapy. The drug is given directly into the bladder weekly for 12 weeks, then monthly for a year if it works. The goal is to see if it can contr…

This study looks at whether adding HyalganBio injections to a physical exercise program helps people with shoulder osteoarthritis move better and feel less pain. About 72 adults aged 45 to 85 with chronic shoulder pain will be split into two groups: one gets three weekly injectio…

This study tests a gel called Hyalo Gyn® to see if it helps with vaginal dryness in women who have had breast cancer and are past menopause. About 156 women will use the gel or a placebo every three days for 12 weeks. The goal is to see if the gel reduces dryness and other sympto…